This small-cap inventory, engaged in designing, manufacturing, and supplying custom-engineered tools for drying and warmth restoration options throughout industrial sectors like chemical compounds, meals, and vitality, is in focus after the corporate expects 65 % income development in FY26.
With a market capitalization of Rs. 2,088.33 crore, the shares of Kilburn Engineering Restricted closed at Rs. 437 per fairness share, up almost 0.16 % from its earlier day’s shut worth of Rs. 436.30.
Income Steerage: Kilburn Engineering Restricted has shared a powerful development outlook for FY26, aiming for a 50 % year-on-year income improve. The corporate targets a high line of Rs. 650–700 crore (consists of income from Monga Strayfield), which is strictly 65.09 % development in comparison with FY25 income.
Wanting forward, Kilburn’s administration is assured of sustaining momentum, projecting a 25-30 % CAGR within the years past FY26. This steering displays robust demand, environment friendly execution, and the corporate’s strategic positioning within the industrial engineering and thermal processing segments.
Margin Steerage
The corporate has offered margin steering for its operations. The consolidated EBITDA margin is anticipated to be between 20-22 %, with Monga Strayfield concentrating on 24–25 %, M.E. Vitality aiming for 15–17 %, and Kilburn’s standalone projected to attain a barely greater margin.
Order Guide
Kilburn Engineering Restricted’s complete order e-book stands at Rs. 450.41 crore, which incorporates its subsidiary, Monga Strayfield’s order of Rs. 62.78 crore as of March 2025. The corporate’s standalone closing order e-book worth stands at Rs. 387.62 crore. It’s diversified throughout numerous sectors, with oil & gasoline (Rs. 33.40 crore) contributing 8.6 % and nuclear energy (Rs. 49 crore) at 12.6 %.
Moreover, the corporate additionally obtained orders from chemical (Rs. 57.83 crore) at 14.9 %, petrochemical (Rs. 32.39 crore) at 8.4 %, prescribed drugs (Rs. 18.26 crore) at 4.7 %, fertiliser (Rs. 112.37 crore) at 29 %, tea (Rs. 17.55 crore) at 4.5 %, others (Rs. 8.21 crore) at 2.1 %, and carbon black (Rs. 58.61 crore) at 15.1 %.
Export Order
Kilburn Engineering Restricted has an export order backlog of roughly Rs. 160 crore and is concentrating on 20–30 % of its income from exports throughout the subsequent 2–3 years. This export development can be pushed by all three entities, similar to Kilburn, M.E. Vitality, and Monga Strayfield.
Enlargement: Kilburn Engineering Restricted can be increasing into new areas just like the cement and nuclear sectors, which supply massive alternatives, whereas its entry into the pharma sector is dependent upon profitable buyer trials.
For FY26, the corporate has deliberate an indicative capital expenditure of round Rs. 25 crore, with the ultimate quantity to be determined within the coming quarters. Moreover, they’re contemplating a brownfield enlargement at their Saravali facility.
Overview
Kilburn Engineering Restricted was based in 1987 and relies in Thane, India. The corporate designs, manufactures, provides, installs, and commissions personalized course of tools and industrial drying methods. The corporate serves sectors like chemical compounds, petrochemicals, oil and gasoline, energy, mining, meals processing, and exports its merchandise internationally.
Monetary highlights
Kilburn Engineering Restricted’s income has elevated from Rs. 122 crore in This autumn FY24 to Rs. 127 crore in This autumn FY25, which has grown by 4.10 %. The web revenue has decreased by 13.04 %, from Rs. 23 crore in This autumn FY24 to Rs. 20 crore in This autumn FY25.
When it comes to return ratios, the corporate’s ROCE and ROE stand at 21.5 % and 17.2 %, respectively. Kilburn Engineering Restricted has an earnings per share (EPS) of Rs. 13.1, and its debt-to-equity ratio is 0.19x.
Written By – Nikhil Naik
Disclaimer
The views and funding ideas expressed by funding specialists/broking homes/score businesses on tradebrains.in are their very own, and never that of the web site or its administration. Investing in equities poses a danger of economic losses. Buyers should subsequently train due warning whereas investing or buying and selling in shares. Commerce Brains Applied sciences Personal Restricted or the creator usually are not answerable for any losses triggered on account of the choice based mostly on this text. Please seek the advice of your funding advisor earlier than investing.
